Hidradenocarcinoma
specificA carcinoma with apocrine and less often eccrine differentiation, arising from the sweat glands. It usually presents as a solitary slow growing nodule in the dermis or subcutaneous tissues. It is characterized by a nodular growth pattern and it is often associated with necrotic changes.
17
Centers
17
Active Trials
—
Cancer Funding
Top Centers for Hidradenocarcinoma(17)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive Active Research Program | 52.9 |
| 2 | NCI Comprehensive Active Research Program | 52.9 |
| 3 | Siteman Cancer CenterSt. Louis, MO NCI Comprehensive Active Research Program | 52.9 |
| 4 | UNC Lineberger Comprehensive Cancer CenterChapel Hill, NC NCI Comprehensive Active Research Program | 52.9 |
| 5 | NCI Comprehensive Active Research Program | 52.9 |
| 6 | NCI Comprehensive Active Research Program | 52.9 |
| 7 | USC Norris Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive Active Research Program | 52.9 |
| 8 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program | 52.9 |
| 9 | UC Davis Comprehensive Cancer CenterSacramento, CA NCI Comprehensive Active Research Program | 52.9 |
| 10 | Roswell Park Comprehensive Cancer CenterBuffalo, NY NCI Comprehensive Active Research Program | 52.9 |
| 11 | NCI Clinical Active Research Program | 52.9 |
| 12 | Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical Active Research Program | 52.9 |
| 13 | Dartmouth Cancer CenterLebanon, NH NCI Comprehensive Active Research Program | 52.9 |
| 14 | Rutgers Cancer InstituteNew Brunswick, NJ NCI Comprehensive Active Research Program | 52.9 |
| 15 | University of Illinois Cancer CenterChicago, IL Active Research Program | 52.9 |
| 16 | Boston University Cancer CenterBoston, MA Active Research Program | 52.9 |
| 17 | Cancer Center at IllinoisUrbana, IL Active Research Program | 52.9 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →